Skip to content
Lhasa Logo
  • Our solutions
    • Solutions
      • In silico mutagenicity assessment
      • Skin sensitisation assessment
      • Carcinogenicity assessment
      • Genotoxic impurity evaluation
      • Non-genotoxic impurity assessment
      • Safety profiling in drug discovery
      • Impurity and degradant control
      • Metabolite identification and analysis
      • Nitrosamine impurity risk assessment
    • Data sharing
      • AI/PDE
      • Aromatic amines
      • Complex nitrosamines
      • Elemental impurities
      • Excipients
      • FDA RCA
      • Intermediates
      • Nitrites
  • Our story
    • Our story
    • Our values
    • Our people
    • Our governance
  • Our members
  • Publications
  • Blog
  • News & events
    • News
    • Events
  • Careers
  • Contact us
  • Our solutions
    • Solutions
      • In silico mutagenicity assessment
      • Skin sensitisation assessment
      • Carcinogenicity assessment
      • Genotoxic impurity evaluation
      • Non-genotoxic impurity assessment
      • Safety profiling in drug discovery
      • Impurity and degradant control
      • Metabolite identification and analysis
      • Nitrosamine impurity risk assessment
    • Data sharing
      • AI/PDE
      • Aromatic amines
      • Complex nitrosamines
      • Elemental impurities
      • Excipients
      • FDA RCA
      • Intermediates
      • Nitrites
  • Our story
    • Our story
    • Our values
    • Our people
    • Our governance
  • Our members
  • Publications
  • Blog
  • News & events
    • News
    • Events
  • Careers
  • Contact us

Author name: catherine.trio

It seems we can’t find what you’re looking for. Perhaps searching can help.

Recent Posts

  • Driving efficient early-stage ICH M7 classification through reliable mutagenic and carcinogenic data
  • Applying ICH S1B(R1) in 5 steps: Carcinogenicity assessment made simple with Kaptis
  • ICH M7 control option 4: How to confidently demonstrate control of mutagenic impurities in API synthesis (without analytical testing)
  • EUROTOX 2025: Highlights from Athens
  • The power of in silico structure searching to achieve data driven decision making with confidence

Recent Comments

No comments to show.

Archives

  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020

Categories

  • Discuss
  • Innovate
  • Life at Lhasa
  • News
Get in touch
Lhasa Logo

Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK
Tel: +44 (0)113 394 6020

  • Solutions
  • Data sharing
  • News
  • Events
  • Publications
  • Blog
  • Solutions
  • Data sharing
  • News
  • Events
  • Publications
  • Blog
  • Careers
  • Our story
  • Our members
  • Contact us
  • Privacy policy
  • Cookie policy
  • Careers
  • Our story
  • Our members
  • Contact us
  • Privacy policy
  • Cookie policy

Sign up to our newsletter

Sign Up

© 2025 Lhasa Limited, All rights reserved | Company registration number: 01765239 |
VAT number: 396 8737 77 | Registered charity number: 290866 | Governing documents

Connect with us

Linkedin-in Instagram